| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anorexia Nervosa | 21 | 2019 | 1328 | 1.120 |
Why?
|
| Bone Density | 21 | 2019 | 3491 | 0.700 |
Why?
|
| Dehydroepiandrosterone | 8 | 2019 | 248 | 0.650 |
Why?
|
| Vitamin D Deficiency | 14 | 2015 | 1348 | 0.650 |
Why?
|
| Cerebral Ventricles | 9 | 2012 | 550 | 0.600 |
Why?
|
| Infant, Premature | 14 | 2021 | 2121 | 0.540 |
Why?
|
| Overweight | 14 | 2020 | 2444 | 0.540 |
Why?
|
| Diet, Carbohydrate-Restricted | 8 | 2018 | 263 | 0.520 |
Why?
|
| Puberty, Delayed | 3 | 2022 | 124 | 0.520 |
Why?
|
| Placenta | 5 | 2024 | 1726 | 0.510 |
Why?
|
| Erectile Dysfunction | 9 | 2000 | 437 | 0.510 |
Why?
|
| Energy Metabolism | 14 | 2018 | 2894 | 0.500 |
Why?
|
| Intensive Care Units, Neonatal | 5 | 2024 | 858 | 0.490 |
Why?
|
| Obesity | 33 | 2023 | 13082 | 0.480 |
Why?
|
| Energy Intake | 15 | 2017 | 2141 | 0.440 |
Why?
|
| Neonatology | 3 | 2021 | 142 | 0.420 |
Why?
|
| Body Composition | 15 | 2021 | 2441 | 0.420 |
Why?
|
| Hydrocephalus | 3 | 2023 | 766 | 0.420 |
Why?
|
| Adolescent | 117 | 2022 | 88811 | 0.400 |
Why?
|
| Fetus | 11 | 2024 | 1878 | 0.390 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 2020 | 419 | 0.390 |
Why?
|
| Sex Characteristics | 6 | 2022 | 2645 | 0.380 |
Why?
|
| Body Mass Index | 31 | 2022 | 13042 | 0.380 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2020 | 329 | 0.380 |
Why?
|
| Female | 221 | 2024 | 396141 | 0.370 |
Why?
|
| Infant, Premature, Diseases | 6 | 2019 | 712 | 0.360 |
Why?
|
| Absorptiometry, Photon | 19 | 2019 | 1707 | 0.360 |
Why?
|
| Uterine Contraction | 2 | 2022 | 90 | 0.360 |
Why?
|
| Weight Loss | 9 | 2019 | 2710 | 0.350 |
Why?
|
| Hyperoxia | 2 | 2022 | 259 | 0.340 |
Why?
|
| Magnetic Resonance Imaging | 26 | 2023 | 36547 | 0.340 |
Why?
|
| Diet, Fat-Restricted | 6 | 2017 | 328 | 0.330 |
Why?
|
| Prenatal Diagnosis | 5 | 2021 | 1271 | 0.330 |
Why?
|
| Platelet Transfusion | 3 | 2022 | 301 | 0.330 |
Why?
|
| Child | 96 | 2024 | 80568 | 0.330 |
Why?
|
| Infant, Newborn | 41 | 2024 | 26380 | 0.330 |
Why?
|
| Humans | 292 | 2024 | 765926 | 0.320 |
Why?
|
| Male | 207 | 2024 | 363815 | 0.320 |
Why?
|
| Dehydroepiandrosterone Sulfate | 3 | 2001 | 238 | 0.320 |
Why?
|
| Vitamin D | 17 | 2018 | 3272 | 0.320 |
Why?
|
| Parenteral Nutrition | 6 | 2012 | 661 | 0.310 |
Why?
|
| Iodide Peroxidase | 3 | 2014 | 295 | 0.300 |
Why?
|
| Contraception Behavior | 1 | 2010 | 185 | 0.300 |
Why?
|
| Thyroid Nodule | 4 | 2018 | 765 | 0.300 |
Why?
|
| Condoms | 1 | 2010 | 336 | 0.300 |
Why?
|
| Oximetry | 3 | 2020 | 458 | 0.300 |
Why?
|
| Exercise | 19 | 2020 | 5936 | 0.290 |
Why?
|
| Abdominal Fat | 1 | 2009 | 217 | 0.290 |
Why?
|
| Dental Care for Aged | 4 | 1996 | 33 | 0.280 |
Why?
|
| Weight Gain | 6 | 2019 | 2356 | 0.270 |
Why?
|
| Thrombocytopenia | 3 | 2020 | 1172 | 0.270 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2023 | 587 | 0.260 |
Why?
|
| Diet, Reducing | 4 | 2017 | 487 | 0.260 |
Why?
|
| Fetal Blood | 2 | 2023 | 1365 | 0.260 |
Why?
|
| Norethindrone | 2 | 2016 | 52 | 0.250 |
Why?
|
| Puberty | 4 | 2021 | 495 | 0.250 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2019 | 409 | 0.250 |
Why?
|
| Feeding Behavior | 11 | 2017 | 3209 | 0.250 |
Why?
|
| Adiposity | 3 | 2018 | 1891 | 0.250 |
Why?
|
| Analysis of Variance | 17 | 2013 | 6202 | 0.240 |
Why?
|
| Sweetening Agents | 2 | 2020 | 291 | 0.240 |
Why?
|
| Beverages | 3 | 2020 | 819 | 0.230 |
Why?
|
| Health Behavior | 15 | 2015 | 2649 | 0.230 |
Why?
|
| Levonorgestrel | 4 | 2019 | 76 | 0.230 |
Why?
|
| Ethinyl Estradiol | 4 | 2019 | 111 | 0.230 |
Why?
|
| Glycemic Index | 6 | 2017 | 400 | 0.230 |
Why?
|
| Malnutrition | 3 | 2020 | 629 | 0.220 |
Why?
|
| Cranial Irradiation | 2 | 2020 | 384 | 0.220 |
Why?
|
| Hormone Replacement Therapy | 4 | 2018 | 752 | 0.220 |
Why?
|
| Fetal Development | 4 | 2024 | 777 | 0.220 |
Why?
|
| Anthropometry | 12 | 2018 | 1339 | 0.220 |
Why?
|
| Infant | 34 | 2024 | 36426 | 0.220 |
Why?
|
| Community Health Services | 3 | 2016 | 657 | 0.220 |
Why?
|
| Home Care Services, Hospital-Based | 2 | 2020 | 44 | 0.220 |
Why?
|
| Knee | 3 | 2017 | 273 | 0.210 |
Why?
|
| Rest | 3 | 2015 | 940 | 0.210 |
Why?
|
| Brain | 11 | 2024 | 27179 | 0.210 |
Why?
|
| Adipose Tissue | 7 | 2017 | 3314 | 0.210 |
Why?
|
| Diet | 15 | 2017 | 8087 | 0.210 |
Why?
|
| Hormones | 4 | 2012 | 865 | 0.210 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 8 | 2015 | 5752 | 0.210 |
Why?
|
| Tooth Abnormalities | 1 | 2023 | 56 | 0.210 |
Why?
|
| Nutrition Assessment | 3 | 2017 | 738 | 0.210 |
Why?
|
| Ergocalciferols | 2 | 2015 | 105 | 0.200 |
Why?
|
| Gastric Bypass | 2 | 2023 | 820 | 0.200 |
Why?
|
| Pregnancy | 25 | 2024 | 30230 | 0.200 |
Why?
|
| Cerebrum | 1 | 2023 | 132 | 0.200 |
Why?
|
| Megakaryocyte Progenitor Cells | 1 | 2022 | 27 | 0.200 |
Why?
|
| Puberty, Precocious | 2 | 2020 | 165 | 0.200 |
Why?
|
| Body Weight | 15 | 2020 | 4627 | 0.200 |
Why?
|
| Twins, Monozygotic | 1 | 2024 | 470 | 0.190 |
Why?
|
| Bone Diseases, Developmental | 1 | 2023 | 131 | 0.190 |
Why?
|
| Aging | 6 | 2002 | 8725 | 0.190 |
Why?
|
| Lutein | 1 | 2022 | 122 | 0.190 |
Why?
|
| Anemia, Neonatal | 1 | 2021 | 19 | 0.190 |
Why?
|
| Blood Platelets | 2 | 2023 | 2464 | 0.190 |
Why?
|
| Child Behavior Disorders | 2 | 2020 | 812 | 0.190 |
Why?
|
| Breast Feeding | 2 | 2022 | 1363 | 0.190 |
Why?
|
| Research Design | 9 | 2017 | 6204 | 0.190 |
Why?
|
| Osteoporosis | 4 | 2016 | 1582 | 0.190 |
Why?
|
| Ultrasonography, Prenatal | 7 | 2023 | 1772 | 0.180 |
Why?
|
| School Health Services | 7 | 2015 | 388 | 0.180 |
Why?
|
| Sexual Behavior | 2 | 2011 | 2192 | 0.180 |
Why?
|
| Health Promotion | 9 | 2015 | 2208 | 0.180 |
Why?
|
| Young Adult | 37 | 2023 | 59857 | 0.180 |
Why?
|
| Body Constitution | 3 | 2022 | 272 | 0.180 |
Why?
|
| Dietary Carbohydrates | 6 | 2017 | 896 | 0.180 |
Why?
|
| Tibia | 4 | 2019 | 1064 | 0.180 |
Why?
|
| Adult | 90 | 2023 | 223088 | 0.180 |
Why?
|
| Massachusetts | 25 | 2017 | 8882 | 0.180 |
Why?
|
| Anemia | 2 | 2021 | 1514 | 0.180 |
Why?
|
| Insulin Resistance | 6 | 2017 | 3988 | 0.180 |
Why?
|
| Neural Tube Defects | 1 | 2023 | 256 | 0.180 |
Why?
|
| Data Interpretation, Statistical | 4 | 2001 | 2688 | 0.180 |
Why?
|
| Statistics as Topic | 9 | 2011 | 2350 | 0.180 |
Why?
|
| Double-Blind Method | 15 | 2019 | 12417 | 0.170 |
Why?
|
| Estrogens, Conjugated (USP) | 3 | 2018 | 274 | 0.170 |
Why?
|
| Respiratory System Agents | 1 | 2020 | 30 | 0.170 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2011 | 4037 | 0.170 |
Why?
|
| Triglycerides | 7 | 2020 | 2440 | 0.170 |
Why?
|
| Erythrocyte Count | 1 | 2020 | 157 | 0.170 |
Why?
|
| Coitus | 2 | 2011 | 133 | 0.170 |
Why?
|
| Prospective Studies | 37 | 2023 | 54807 | 0.170 |
Why?
|
| Mucositis | 2 | 2014 | 107 | 0.170 |
Why?
|
| Testosterone | 5 | 2022 | 2495 | 0.170 |
Why?
|
| Thyroid Neoplasms | 4 | 2018 | 2354 | 0.170 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2016 | 1142 | 0.170 |
Why?
|
| Cohort Studies | 30 | 2023 | 41680 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 11 | 2020 | 10380 | 0.170 |
Why?
|
| Child, Preschool | 32 | 2020 | 42510 | 0.170 |
Why?
|
| Stem Cell Niche | 1 | 2023 | 347 | 0.170 |
Why?
|
| Taste | 2 | 2020 | 190 | 0.170 |
Why?
|
| Obesity, Morbid | 2 | 2023 | 1293 | 0.160 |
Why?
|
| Homocysteine | 3 | 2012 | 638 | 0.160 |
Why?
|
| Baths | 1 | 2019 | 52 | 0.160 |
Why?
|
| Nutritional Requirements | 3 | 2011 | 276 | 0.160 |
Why?
|
| Gestational Age | 10 | 2023 | 3616 | 0.160 |
Why?
|
| Cross-Sectional Studies | 31 | 2022 | 26282 | 0.160 |
Why?
|
| Bone and Bones | 4 | 2012 | 2555 | 0.160 |
Why?
|
| Moyamoya Disease | 1 | 2023 | 273 | 0.160 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2023 | 361 | 0.160 |
Why?
|
| Cardiovascular Diseases | 25 | 2015 | 15645 | 0.160 |
Why?
|
| Bleeding Time | 1 | 2019 | 83 | 0.160 |
Why?
|
| Sampling Studies | 4 | 2001 | 610 | 0.160 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2019 | 65 | 0.160 |
Why?
|
| Models, Statistical | 5 | 2001 | 5088 | 0.160 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2019 | 81 | 0.160 |
Why?
|
| Logistic Models | 19 | 2024 | 13273 | 0.160 |
Why?
|
| Age Factors | 18 | 2023 | 18382 | 0.160 |
Why?
|
| Fractures, Bone | 4 | 2018 | 2041 | 0.150 |
Why?
|
| Prevalence | 23 | 2018 | 15828 | 0.150 |
Why?
|
| Connexins | 2 | 2011 | 355 | 0.150 |
Why?
|
| Cerebral Infarction | 4 | 2007 | 968 | 0.150 |
Why?
|
| Regression Analysis | 18 | 2010 | 6321 | 0.150 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2011 | 781 | 0.150 |
Why?
|
| Chlorhexidine | 1 | 2019 | 159 | 0.150 |
Why?
|
| Cleft Lip | 1 | 2024 | 512 | 0.150 |
Why?
|
| Hemiplegia | 1 | 2018 | 136 | 0.150 |
Why?
|
| Insulin | 8 | 2018 | 6603 | 0.150 |
Why?
|
| Myocardial Infarction | 9 | 2004 | 11508 | 0.150 |
Why?
|
| Hemorrhage | 3 | 2020 | 3466 | 0.150 |
Why?
|
| Platelet Function Tests | 1 | 2020 | 276 | 0.150 |
Why?
|
| Femur Neck | 3 | 2015 | 316 | 0.150 |
Why?
|
| Cleft Palate | 1 | 2024 | 596 | 0.150 |
Why?
|
| Hypothermia, Induced | 1 | 2023 | 754 | 0.150 |
Why?
|
| Developmental Disabilities | 2 | 2021 | 1519 | 0.150 |
Why?
|
| Immunoglobulins, Thyroid-Stimulating | 1 | 2017 | 34 | 0.150 |
Why?
|
| Child Restraint Systems | 1 | 2017 | 20 | 0.150 |
Why?
|
| Placenta Diseases | 1 | 2020 | 199 | 0.140 |
Why?
|
| Hematology | 1 | 2021 | 243 | 0.140 |
Why?
|
| Risk Factors | 54 | 2017 | 74850 | 0.140 |
Why?
|
| Dietary Sucrose | 2 | 2012 | 241 | 0.140 |
Why?
|
| Dietary Fats | 10 | 2017 | 2002 | 0.140 |
Why?
|
| Smoking | 12 | 2002 | 9082 | 0.140 |
Why?
|
| Parathyroid Hormone | 8 | 2013 | 1790 | 0.140 |
Why?
|
| Patient Positioning | 1 | 2020 | 329 | 0.140 |
Why?
|
| Endometriosis | 2 | 2016 | 869 | 0.140 |
Why?
|
| Thyroglobulin | 1 | 2017 | 111 | 0.140 |
Why?
|
| Physical Education and Training | 4 | 2001 | 102 | 0.140 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2019 | 246 | 0.140 |
Why?
|
| Sex Distribution | 11 | 2021 | 2269 | 0.140 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2019 | 260 | 0.130 |
Why?
|
| Catheter-Related Infections | 1 | 2019 | 279 | 0.130 |
Why?
|
| Sentinel Surveillance | 1 | 2018 | 292 | 0.130 |
Why?
|
| Body Fluid Compartments | 2 | 2017 | 49 | 0.130 |
Why?
|
| Osteocalcin | 3 | 2013 | 271 | 0.130 |
Why?
|
| Periodontal Diseases | 6 | 2008 | 453 | 0.130 |
Why?
|
| Decision Making | 5 | 2018 | 3955 | 0.130 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 702 | 0.130 |
Why?
|
| Congenital Hypothyroidism | 1 | 2016 | 40 | 0.130 |
Why?
|
| Cerebral Cortex | 3 | 2022 | 5765 | 0.130 |
Why?
|
| Apnea | 1 | 2017 | 193 | 0.130 |
Why?
|
| Malformations of Cortical Development | 1 | 2018 | 174 | 0.130 |
Why?
|
| Erythrocyte Transfusion | 1 | 2021 | 574 | 0.130 |
Why?
|
| Angina, Unstable | 1 | 2000 | 893 | 0.130 |
Why?
|
| Root Caries | 3 | 1996 | 16 | 0.130 |
Why?
|
| Health Education | 6 | 2004 | 1060 | 0.130 |
Why?
|
| Contraceptives, Oral, Combined | 2 | 2014 | 116 | 0.130 |
Why?
|
| Videotape Recording | 1 | 1997 | 333 | 0.130 |
Why?
|
| Infant Formula | 1 | 2017 | 192 | 0.130 |
Why?
|
| Thrombocytopenia, Neonatal Alloimmune | 1 | 2015 | 19 | 0.120 |
Why?
|
| Therapeutics | 1 | 1996 | 113 | 0.120 |
Why?
|
| Child Development | 3 | 2021 | 2327 | 0.120 |
Why?
|
| Abnormalities, Multiple | 1 | 2023 | 1424 | 0.120 |
Why?
|
| Patient Selection | 5 | 2013 | 4248 | 0.120 |
Why?
|
| New England | 12 | 2017 | 1059 | 0.120 |
Why?
|
| Medulloblastoma | 1 | 2020 | 657 | 0.120 |
Why?
|
| Antigens, Human Platelet | 1 | 2015 | 41 | 0.120 |
Why?
|
| Pilot Projects | 10 | 2022 | 8724 | 0.120 |
Why?
|
| Vancomycin | 3 | 2015 | 504 | 0.120 |
Why?
|
| Nutritional Status | 5 | 2017 | 1620 | 0.120 |
Why?
|
| Drug Utilization | 2 | 2020 | 1187 | 0.120 |
Why?
|
| Random Allocation | 8 | 2013 | 2394 | 0.120 |
Why?
|
| Dietary Supplements | 7 | 2018 | 3427 | 0.120 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2019 | 328 | 0.120 |
Why?
|
| Thrombopoietin | 1 | 2017 | 225 | 0.120 |
Why?
|
| Triiodothyronine | 2 | 2016 | 493 | 0.120 |
Why?
|
| Diagnosis | 1 | 1996 | 157 | 0.120 |
Why?
|
| Phosphoproteins | 1 | 2023 | 2444 | 0.120 |
Why?
|
| Adolescent Development | 1 | 2018 | 273 | 0.120 |
Why?
|
| Temporal Lobe | 1 | 2022 | 1715 | 0.120 |
Why?
|
| Sex Factors | 16 | 2019 | 10611 | 0.120 |
Why?
|
| Lumbar Vertebrae | 2 | 2015 | 1878 | 0.120 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2015 | 129 | 0.120 |
Why?
|
| Vibration | 1 | 2016 | 334 | 0.120 |
Why?
|
| Cytodiagnosis | 1 | 2018 | 450 | 0.120 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2015 | 82 | 0.120 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2017 | 352 | 0.120 |
Why?
|
| Time Factors | 36 | 2022 | 40097 | 0.120 |
Why?
|
| Zebrafish | 3 | 2023 | 3035 | 0.110 |
Why?
|
| Bicarbonates | 1 | 2015 | 293 | 0.110 |
Why?
|
| Birds | 1 | 1995 | 165 | 0.110 |
Why?
|
| Critical Illness | 3 | 2024 | 2749 | 0.110 |
Why?
|
| Leuprolide | 1 | 2016 | 310 | 0.110 |
Why?
|
| Xylitol | 1 | 2014 | 23 | 0.110 |
Why?
|
| Quality Improvement | 2 | 2021 | 3847 | 0.110 |
Why?
|
| Citrulline | 1 | 2014 | 106 | 0.110 |
Why?
|
| Drug Utilization Review | 2 | 2005 | 248 | 0.110 |
Why?
|
| Fetal Diseases | 2 | 2011 | 915 | 0.110 |
Why?
|
| Bed Rest | 2 | 2016 | 82 | 0.110 |
Why?
|
| Cerebral Palsy | 1 | 2018 | 481 | 0.110 |
Why?
|
| Reproducibility of Results | 18 | 2021 | 20133 | 0.110 |
Why?
|
| Ultrasonography | 5 | 2018 | 5987 | 0.110 |
Why?
|
| Telephone | 1 | 1997 | 627 | 0.110 |
Why?
|
| Neurogenesis | 1 | 2020 | 863 | 0.110 |
Why?
|
| Diet Records | 2 | 2002 | 425 | 0.110 |
Why?
|
| Bone Marrow | 2 | 2017 | 2916 | 0.110 |
Why?
|
| Age Distribution | 7 | 2006 | 2864 | 0.110 |
Why?
|
| Myocardial Ischemia | 2 | 2002 | 2132 | 0.110 |
Why?
|
| Adolescent Behavior | 4 | 2012 | 1184 | 0.110 |
Why?
|
| Receptors, Fc | 1 | 2017 | 537 | 0.110 |
Why?
|
| Collagen | 3 | 2011 | 2616 | 0.110 |
Why?
|
| Postprandial Period | 2 | 2013 | 320 | 0.110 |
Why?
|
| Patient Discharge | 4 | 2020 | 3460 | 0.110 |
Why?
|
| Cholesterol, HDL | 6 | 2020 | 1813 | 0.110 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2023 | 2805 | 0.110 |
Why?
|
| Encephalomyelitis, Eastern Equine | 1 | 2013 | 14 | 0.110 |
Why?
|
| Primary Health Care | 5 | 2016 | 4736 | 0.110 |
Why?
|
| Students | 5 | 2015 | 1741 | 0.110 |
Why?
|
| Thyroxine | 2 | 2016 | 665 | 0.110 |
Why?
|
| Respiratory Tract Infections | 2 | 2015 | 1008 | 0.110 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 2 | 2009 | 245 | 0.100 |
Why?
|
| Bone Remodeling | 1 | 2016 | 577 | 0.100 |
Why?
|
| Cities | 1 | 2015 | 542 | 0.100 |
Why?
|
| Ethics, Medical | 1 | 2018 | 785 | 0.100 |
Why?
|
| Cholecalciferol | 2 | 2015 | 550 | 0.100 |
Why?
|
| Milk, Human | 1 | 2017 | 490 | 0.100 |
Why?
|
| Liver Regeneration | 1 | 2014 | 213 | 0.100 |
Why?
|
| Metabolomics | 2 | 2019 | 1667 | 0.100 |
Why?
|
| Retrospective Studies | 25 | 2024 | 81537 | 0.100 |
Why?
|
| Schools | 6 | 2015 | 1496 | 0.100 |
Why?
|
| Sexual and Gender Disorders | 1 | 2012 | 6 | 0.100 |
Why?
|
| Down Syndrome | 1 | 2021 | 915 | 0.100 |
Why?
|
| Quality of Life | 4 | 2020 | 13463 | 0.100 |
Why?
|
| Blood Glucose | 5 | 2023 | 6422 | 0.100 |
Why?
|
| Depression | 3 | 2010 | 8223 | 0.100 |
Why?
|
| Computers | 4 | 2006 | 588 | 0.100 |
Why?
|
| Boston | 8 | 2017 | 9334 | 0.100 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2015 | 252 | 0.100 |
Why?
|
| Program Evaluation | 6 | 2004 | 2502 | 0.100 |
Why?
|
| Chest Pain | 4 | 2002 | 1102 | 0.100 |
Why?
|
| Thyroid Hormones | 2 | 2014 | 408 | 0.100 |
Why?
|
| Metformin | 2 | 2010 | 904 | 0.100 |
Why?
|
| Catheterization, Peripheral | 1 | 2015 | 345 | 0.100 |
Why?
|
| Folic Acid Deficiency | 1 | 2012 | 117 | 0.100 |
Why?
|
| Epidemiologic Methods | 3 | 2000 | 1325 | 0.100 |
Why?
|
| Referral and Consultation | 3 | 2016 | 3615 | 0.100 |
Why?
|
| Psychometrics | 3 | 2018 | 3061 | 0.090 |
Why?
|
| Thalamus | 1 | 2018 | 1048 | 0.090 |
Why?
|
| Cholesterol | 11 | 2010 | 2902 | 0.090 |
Why?
|
| Mouth Mucosa | 1 | 2014 | 432 | 0.090 |
Why?
|
| Coronary Disease | 5 | 2000 | 5919 | 0.090 |
Why?
|
| Dental Caries | 4 | 1996 | 429 | 0.090 |
Why?
|
| Otitis Media | 1 | 2014 | 287 | 0.090 |
Why?
|
| Rickets | 1 | 2011 | 66 | 0.090 |
Why?
|
| Body Size | 1 | 2014 | 460 | 0.090 |
Why?
|
| Recreation | 1 | 2012 | 124 | 0.090 |
Why?
|
| Lung | 12 | 2006 | 10046 | 0.090 |
Why?
|
| Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2011 | 13 | 0.090 |
Why?
|
| Food, Fortified | 1 | 2012 | 189 | 0.090 |
Why?
|
| Follow-Up Studies | 20 | 2020 | 39228 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2023 | 2061 | 0.090 |
Why?
|
| Megakaryocytes | 1 | 2015 | 557 | 0.090 |
Why?
|
| Body Height | 3 | 2020 | 1561 | 0.090 |
Why?
|
| Galactosemias | 1 | 2012 | 124 | 0.090 |
Why?
|
| Alkaline Phosphatase | 3 | 2009 | 855 | 0.090 |
Why?
|
| Cerebral Hemorrhage | 3 | 2007 | 2649 | 0.090 |
Why?
|
| Estrogens | 4 | 2016 | 1528 | 0.090 |
Why?
|
| Severity of Illness Index | 7 | 2020 | 15878 | 0.090 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2011 | 153 | 0.090 |
Why?
|
| Mathematics | 9 | 1995 | 696 | 0.090 |
Why?
|
| United States | 36 | 2019 | 72909 | 0.090 |
Why?
|
| Septum Pellucidum | 1 | 2011 | 55 | 0.090 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2015 | 391 | 0.090 |
Why?
|
| Nutritive Value | 2 | 2012 | 350 | 0.090 |
Why?
|
| Genetic Testing | 1 | 2024 | 3594 | 0.090 |
Why?
|
| Conscious Sedation | 2 | 2006 | 533 | 0.090 |
Why?
|
| Pleasure | 1 | 2010 | 41 | 0.090 |
Why?
|
| Vitamins | 5 | 2015 | 1631 | 0.090 |
Why?
|
| Cross Infection | 1 | 2019 | 1426 | 0.090 |
Why?
|
| Aged | 43 | 2019 | 171163 | 0.090 |
Why?
|
| Contraceptive Agents, Female | 1 | 2011 | 122 | 0.090 |
Why?
|
| Catheterization, Central Venous | 1 | 2015 | 538 | 0.090 |
Why?
|
| Cricetinae | 9 | 1991 | 2412 | 0.090 |
Why?
|
| Skull Fractures | 1 | 2011 | 202 | 0.090 |
Why?
|
| Play and Playthings | 1 | 2010 | 85 | 0.080 |
Why?
|
| Pediatrics | 6 | 2018 | 3609 | 0.080 |
Why?
|
| Proteomics | 1 | 2023 | 3906 | 0.080 |
Why?
|
| Progestins | 1 | 2012 | 300 | 0.080 |
Why?
|
| Lung Transplantation | 2 | 2018 | 1311 | 0.080 |
Why?
|
| Tooth Diseases | 3 | 1996 | 73 | 0.080 |
Why?
|
| Models, Biological | 12 | 1995 | 9443 | 0.080 |
Why?
|
| Lung Volume Measurements | 3 | 2006 | 381 | 0.080 |
Why?
|
| Metabolome | 1 | 2017 | 1005 | 0.080 |
Why?
|
| Dwarfism | 1 | 2010 | 137 | 0.080 |
Why?
|
| Heart Diseases | 5 | 2000 | 2818 | 0.080 |
Why?
|
| Cytokines | 2 | 2022 | 7417 | 0.080 |
Why?
|
| Rhode Island | 7 | 2001 | 351 | 0.080 |
Why?
|
| Reference Values | 6 | 2010 | 4909 | 0.080 |
Why?
|
| Middle Aged | 47 | 2022 | 223016 | 0.080 |
Why?
|
| Mammals | 1 | 1995 | 1126 | 0.080 |
Why?
|
| Statistics, Nonparametric | 5 | 2012 | 2844 | 0.080 |
Why?
|
| Oxygen | 6 | 2024 | 4246 | 0.080 |
Why?
|
| Physician's Role | 1 | 1996 | 925 | 0.080 |
Why?
|
| Health Care Surveys | 2 | 2013 | 2426 | 0.080 |
Why?
|
| Hypothyroidism | 1 | 2014 | 665 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2009 | 126 | 0.080 |
Why?
|
| Pregnancy Outcome | 4 | 2012 | 2969 | 0.080 |
Why?
|
| Sensitivity and Specificity | 8 | 2015 | 14643 | 0.080 |
Why?
|
| Lipids | 5 | 2017 | 3317 | 0.080 |
Why?
|
| Cross-Over Studies | 5 | 2017 | 2108 | 0.080 |
Why?
|
| Vitamin B Complex | 2 | 2012 | 299 | 0.080 |
Why?
|
| Mitogens | 1 | 2009 | 228 | 0.080 |
Why?
|
| Menstrual Cycle | 2 | 2010 | 539 | 0.080 |
Why?
|
| Respiration | 7 | 1991 | 1653 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 3733 | 0.080 |
Why?
|
| Graft vs Host Disease | 2 | 2014 | 3079 | 0.080 |
Why?
|
| Predictive Value of Tests | 8 | 2015 | 15401 | 0.080 |
Why?
|
| Sex Hormone-Binding Globulin | 3 | 2000 | 557 | 0.080 |
Why?
|
| Brain Concussion | 1 | 2019 | 1432 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2021 | 8924 | 0.070 |
Why?
|
| Cystic Fibrosis | 2 | 2015 | 1284 | 0.070 |
Why?
|
| Hypoglycemic Agents | 3 | 2010 | 3106 | 0.070 |
Why?
|
| Drug Therapy, Combination | 5 | 2016 | 6306 | 0.070 |
Why?
|
| Infant Welfare | 1 | 2008 | 78 | 0.070 |
Why?
|
| Food Services | 3 | 2004 | 209 | 0.070 |
Why?
|
| Animals | 43 | 2023 | 168735 | 0.070 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2014 | 616 | 0.070 |
Why?
|
| Hypogonadism | 3 | 2021 | 801 | 0.070 |
Why?
|
| Sepsis | 1 | 2022 | 2603 | 0.070 |
Why?
|
| Kinetics | 9 | 1992 | 6273 | 0.070 |
Why?
|
| Nutrition Policy | 2 | 2002 | 467 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 3048 | 0.070 |
Why?
|
| Physician-Patient Relations | 3 | 1997 | 3270 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 4 | 2015 | 7473 | 0.070 |
Why?
|
| L-Lactate Dehydrogenase | 4 | 1987 | 411 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2017 | 1939 | 0.070 |
Why?
|
| Longitudinal Studies | 12 | 2019 | 14745 | 0.070 |
Why?
|
| Basal Metabolism | 1 | 2008 | 163 | 0.070 |
Why?
|
| Menarche | 1 | 2010 | 532 | 0.070 |
Why?
|
| Hepatocytes | 1 | 2014 | 1247 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2024 | 4712 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 3678 | 0.070 |
Why?
|
| Folic Acid | 2 | 2012 | 1337 | 0.070 |
Why?
|
| Emergency Service, Hospital | 4 | 2006 | 7871 | 0.070 |
Why?
|
| Oral Health | 2 | 2008 | 493 | 0.070 |
Why?
|
| Appetite Regulation | 1 | 2007 | 84 | 0.070 |
Why?
|
| Administration, Oral | 4 | 2018 | 4016 | 0.070 |
Why?
|
| Emergency Medical Services | 5 | 2002 | 1937 | 0.070 |
Why?
|
| Autoantibodies | 1 | 2015 | 2114 | 0.070 |
Why?
|
| Deafness | 1 | 2011 | 461 | 0.070 |
Why?
|
| Fetal Organ Maturity | 1 | 2006 | 83 | 0.070 |
Why?
|
| Radiotherapy | 2 | 2011 | 1491 | 0.070 |
Why?
|
| Ferric Compounds | 2 | 1987 | 367 | 0.070 |
Why?
|
| APUD Cells | 2 | 1982 | 5 | 0.070 |
Why?
|
| Spinal Fractures | 1 | 2013 | 702 | 0.070 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2014 | 958 | 0.070 |
Why?
|
| Temporal Bone | 1 | 2011 | 683 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2020 | 5339 | 0.070 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2007 | 94 | 0.070 |
Why?
|
| Carcinoma | 1 | 2017 | 2311 | 0.060 |
Why?
|
| Patient Simulation | 3 | 1997 | 301 | 0.060 |
Why?
|
| Hematopoiesis | 1 | 2015 | 2060 | 0.060 |
Why?
|
| Gender Identity | 1 | 2012 | 766 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 4 | 2020 | 1729 | 0.060 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 2 | 2006 | 59 | 0.060 |
Why?
|
| Stroke | 3 | 2023 | 9739 | 0.060 |
Why?
|
| Linear Models | 6 | 2019 | 5873 | 0.060 |
Why?
|
| Progesterone | 1 | 2010 | 751 | 0.060 |
Why?
|
| Capnography | 1 | 2006 | 90 | 0.060 |
Why?
|
| Waist Circumference | 1 | 2009 | 934 | 0.060 |
Why?
|
| Neonatal Screening | 1 | 2010 | 619 | 0.060 |
Why?
|
| Insulin, Long-Acting | 1 | 2005 | 59 | 0.060 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2023 | 2415 | 0.060 |
Why?
|
| Treatment Outcome | 14 | 2021 | 65194 | 0.060 |
Why?
|
| Brain Neoplasms | 2 | 2020 | 9065 | 0.060 |
Why?
|
| Saliva | 1 | 2010 | 852 | 0.060 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2012 | 1021 | 0.060 |
Why?
|
| Pulmonary Alveoli | 3 | 1996 | 665 | 0.060 |
Why?
|
| Femur | 2 | 2014 | 1309 | 0.060 |
Why?
|
| Lipoproteins, HDL | 2 | 2009 | 676 | 0.060 |
Why?
|
| Comorbidity | 4 | 2013 | 10575 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 829 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 5 | 1998 | 999 | 0.060 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2009 | 547 | 0.060 |
Why?
|
| DMF Index | 4 | 2008 | 86 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2011 | 3089 | 0.060 |
Why?
|
| Observer Variation | 5 | 2010 | 2611 | 0.060 |
Why?
|
| Frontal Lobe | 2 | 2022 | 1408 | 0.060 |
Why?
|
| Risk Assessment | 7 | 2017 | 24275 | 0.060 |
Why?
|
| Musculoskeletal System | 1 | 2007 | 187 | 0.060 |
Why?
|
| Brain Mapping | 1 | 2020 | 6598 | 0.060 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2005 | 53 | 0.060 |
Why?
|
| Intensive Care, Neonatal | 1 | 2006 | 201 | 0.060 |
Why?
|
| Head | 1 | 2010 | 926 | 0.060 |
Why?
|
| Magnetics | 1 | 1987 | 586 | 0.060 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2014 | 1399 | 0.060 |
Why?
|
| Antidepressive Agents | 1 | 2016 | 2901 | 0.060 |
Why?
|
| Metapneumovirus | 1 | 2004 | 28 | 0.060 |
Why?
|
| Urban Population | 2 | 2008 | 2040 | 0.060 |
Why?
|
| Cerebrospinal Fluid | 1 | 2007 | 540 | 0.060 |
Why?
|
| Hip | 3 | 2014 | 249 | 0.060 |
Why?
|
| Counseling | 3 | 2017 | 1551 | 0.060 |
Why?
|
| Endotoxins | 3 | 1992 | 516 | 0.060 |
Why?
|
| Diaphragm | 7 | 1990 | 356 | 0.060 |
Why?
|
| Paramyxoviridae Infections | 1 | 2004 | 57 | 0.060 |
Why?
|
| Life Style | 5 | 2010 | 3928 | 0.060 |
Why?
|
| Radiography | 6 | 2013 | 6941 | 0.060 |
Why?
|
| Aspartate Carbamoyltransferase | 1 | 1983 | 18 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2010 | 4055 | 0.060 |
Why?
|
| Child Welfare | 1 | 2008 | 521 | 0.060 |
Why?
|
| Lactates | 1 | 2005 | 398 | 0.060 |
Why?
|
| Probability | 5 | 2007 | 2474 | 0.060 |
Why?
|
| Metabolism | 2 | 1977 | 193 | 0.050 |
Why?
|
| Chi-Square Distribution | 5 | 2010 | 3430 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 2008 | 519 | 0.050 |
Why?
|
| Laryngeal Diseases | 1 | 2007 | 248 | 0.050 |
Why?
|
| Minnesota | 4 | 2002 | 339 | 0.050 |
Why?
|
| Platelet Count | 2 | 2021 | 784 | 0.050 |
Why?
|
| Affect | 1 | 2011 | 1494 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2023 | 12129 | 0.050 |
Why?
|
| Radius | 1 | 2006 | 440 | 0.050 |
Why?
|
| Fetal Movement | 1 | 2022 | 21 | 0.050 |
Why?
|
| Hyperlipidemias | 3 | 1994 | 770 | 0.050 |
Why?
|
| Mandible | 1 | 2008 | 746 | 0.050 |
Why?
|
| Total Lung Capacity | 3 | 1994 | 148 | 0.050 |
Why?
|
| Population Surveillance | 4 | 2001 | 2596 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2023 | 23597 | 0.050 |
Why?
|
| Attitude to Health | 2 | 2010 | 2020 | 0.050 |
Why?
|
| Androgens | 3 | 2007 | 1278 | 0.050 |
Why?
|
| Incidence | 8 | 2013 | 21513 | 0.050 |
Why?
|
| Alleles | 2 | 2011 | 6891 | 0.050 |
Why?
|
| Tobacco, Smokeless | 2 | 2002 | 132 | 0.050 |
Why?
|
| C-Reactive Protein | 2 | 2014 | 3851 | 0.050 |
Why?
|
| Cooking | 2 | 2015 | 327 | 0.050 |
Why?
|
| Mice | 10 | 2022 | 81782 | 0.050 |
Why?
|
| Child Abuse | 1 | 2011 | 1090 | 0.050 |
Why?
|
| Vocal Cords | 1 | 2007 | 520 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 4111 | 0.050 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2003 | 222 | 0.050 |
Why?
|
| Thrombolytic Therapy | 2 | 2003 | 2050 | 0.050 |
Why?
|
| Drug Administration Schedule | 3 | 2015 | 4851 | 0.050 |
Why?
|
| Facies | 1 | 2023 | 223 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2013 | 2778 | 0.050 |
Why?
|
| Mental Recall | 7 | 2002 | 1217 | 0.050 |
Why?
|
| Anemia, Sickle Cell | 1 | 2010 | 1063 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2022 | 127 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2016 | 20690 | 0.050 |
Why?
|
| Limulus Test | 2 | 1992 | 19 | 0.050 |
Why?
|
| Infant, Low Birth Weight | 3 | 2021 | 870 | 0.050 |
Why?
|
| Protein Binding | 4 | 1983 | 9296 | 0.050 |
Why?
|
| Androstane-3,17-diol | 1 | 2001 | 20 | 0.050 |
Why?
|
| Monitoring, Ambulatory | 1 | 2005 | 357 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 12235 | 0.050 |
Why?
|
| Antioxidants | 1 | 2009 | 1671 | 0.050 |
Why?
|
| Receptors, Cell Surface | 3 | 1989 | 2814 | 0.050 |
Why?
|
| Blood Pressure | 9 | 2017 | 8530 | 0.050 |
Why?
|
| Enteral Nutrition | 1 | 2007 | 802 | 0.050 |
Why?
|
| Liver | 3 | 2014 | 7559 | 0.050 |
Why?
|
| Hospitalization | 4 | 2016 | 10810 | 0.050 |
Why?
|
| Interviews as Topic | 4 | 1998 | 2740 | 0.050 |
Why?
|
| Models, Theoretical | 3 | 1992 | 3560 | 0.050 |
Why?
|
| Isometric Contraction | 3 | 1993 | 149 | 0.050 |
Why?
|
| Phlebotomy | 1 | 2021 | 138 | 0.040 |
Why?
|
| Prognosis | 6 | 2020 | 29890 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2023 | 947 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2009 | 1389 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 9239 | 0.040 |
Why?
|
| Benzoates | 1 | 2022 | 213 | 0.040 |
Why?
|
| Preventive Medicine | 1 | 2002 | 246 | 0.040 |
Why?
|
| Calcium | 6 | 2012 | 5769 | 0.040 |
Why?
|
| Hydrazines | 1 | 2022 | 223 | 0.040 |
Why?
|
| Collagen Type I | 2 | 2019 | 616 | 0.040 |
Why?
|
| Respiratory Muscles | 2 | 1993 | 144 | 0.040 |
Why?
|
| Chronic Disease | 5 | 2017 | 9351 | 0.040 |
Why?
|
| Solvents | 2 | 1991 | 299 | 0.040 |
Why?
|
| Health Surveys | 6 | 2015 | 4058 | 0.040 |
Why?
|
| Fetal Growth Retardation | 1 | 2024 | 591 | 0.040 |
Why?
|
| Parents | 3 | 2018 | 3591 | 0.040 |
Why?
|
| Diagnosis-Related Groups | 1 | 2001 | 445 | 0.040 |
Why?
|
| Home Care Services | 2 | 2018 | 658 | 0.040 |
Why?
|
| Health Services Research | 2 | 1997 | 1811 | 0.040 |
Why?
|
| Awareness | 1 | 2004 | 653 | 0.040 |
Why?
|
| Minority Groups | 2 | 2024 | 1208 | 0.040 |
Why?
|
| Analgesia | 1 | 2004 | 461 | 0.040 |
Why?
|
| Thyroid Gland | 2 | 2018 | 1168 | 0.040 |
Why?
|
| Genotype | 2 | 2011 | 13026 | 0.040 |
Why?
|
| Demography | 2 | 2002 | 1640 | 0.040 |
Why?
|
| Myocardial Reperfusion | 1 | 2000 | 338 | 0.040 |
Why?
|
| Telemedicine | 1 | 2016 | 3108 | 0.040 |
Why?
|
| Motor Skills | 1 | 2022 | 517 | 0.040 |
Why?
|
| Adenosine Diphosphate | 1 | 2020 | 419 | 0.040 |
Why?
|
| Isoenzymes | 5 | 2014 | 1688 | 0.040 |
Why?
|
| Socioeconomic Factors | 9 | 2002 | 7842 | 0.040 |
Why?
|
| Coronary Care Units | 1 | 2000 | 235 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2020 | 869 | 0.040 |
Why?
|
| Calorimetry, Indirect | 2 | 2010 | 176 | 0.040 |
Why?
|
| Dental Restoration, Permanent | 3 | 1996 | 130 | 0.040 |
Why?
|
| Medication Errors | 1 | 2005 | 784 | 0.040 |
Why?
|
| Community Networks | 1 | 2000 | 202 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2011 | 3712 | 0.040 |
Why?
|
| Single-Blind Method | 2 | 2014 | 1587 | 0.040 |
Why?
|
| Uterus | 1 | 2022 | 660 | 0.040 |
Why?
|
| Risk-Taking | 3 | 2007 | 1021 | 0.040 |
Why?
|
| Simian virus 40 | 1 | 1978 | 290 | 0.040 |
Why?
|
| Sexual Maturation | 1 | 2019 | 256 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2009 | 3140 | 0.040 |
Why?
|
| Lipoproteins, VLDL | 1 | 1979 | 198 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2021 | 2676 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2003 | 705 | 0.040 |
Why?
|
| Sample Size | 2 | 2008 | 843 | 0.040 |
Why?
|
| Time | 1 | 2019 | 549 | 0.040 |
Why?
|
| Case-Control Studies | 5 | 2016 | 22228 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2018 | 5945 | 0.040 |
Why?
|
| Early Diagnosis | 2 | 2013 | 1186 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2012 | 2307 | 0.040 |
Why?
|
| Maternal Age | 1 | 2021 | 804 | 0.040 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 5889 | 0.040 |
Why?
|
| Mesocricetus | 6 | 1991 | 256 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2019 | 706 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 2 | 2005 | 1607 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 261 | 0.040 |
Why?
|
| Radioactive Tracers | 1 | 1977 | 61 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 1983 | 1136 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 1194 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 2018 | 570 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2015 | 10727 | 0.040 |
Why?
|
| Aerosols | 5 | 1992 | 634 | 0.040 |
Why?
|
| Parietal Lobe | 1 | 2022 | 859 | 0.040 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 208 | 0.030 |
Why?
|
| Heart | 1 | 2010 | 4419 | 0.030 |
Why?
|
| Macrophages | 3 | 1991 | 5772 | 0.030 |
Why?
|
| Obesity, Abdominal | 1 | 2020 | 370 | 0.030 |
Why?
|
| Glycerides | 1 | 2017 | 67 | 0.030 |
Why?
|
| Audiometry | 2 | 2010 | 253 | 0.030 |
Why?
|
| Patient Compliance | 3 | 2017 | 2693 | 0.030 |
Why?
|
| Multivariate Analysis | 5 | 2013 | 12059 | 0.030 |
Why?
|
| Cluster Analysis | 2 | 1994 | 2717 | 0.030 |
Why?
|
| Diet Surveys | 3 | 2006 | 1159 | 0.030 |
Why?
|
| Airway Resistance | 2 | 1996 | 407 | 0.030 |
Why?
|
| Spine | 3 | 2009 | 1132 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 18292 | 0.030 |
Why?
|
| Dental Health Surveys | 2 | 1994 | 39 | 0.030 |
Why?
|
| Aged, 80 and over | 14 | 2010 | 59496 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2010 | 2970 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2023 | 2194 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2005 | 1590 | 0.030 |
Why?
|
| Syndrome | 1 | 2023 | 3271 | 0.030 |
Why?
|
| Birth Weight | 2 | 2018 | 2122 | 0.030 |
Why?
|
| Contraceptives, Oral, Synthetic | 1 | 2016 | 15 | 0.030 |
Why?
|
| Decision Theory | 1 | 1996 | 27 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2011 | 13446 | 0.030 |
Why?
|
| Hydrocortisone | 3 | 2013 | 1832 | 0.030 |
Why?
|
| Fatty Acids | 2 | 2002 | 1804 | 0.030 |
Why?
|
| Human Growth Hormone | 2 | 2011 | 639 | 0.030 |
Why?
|
| Tobacco Use Disorder | 1 | 2002 | 708 | 0.030 |
Why?
|
| Food | 2 | 2015 | 764 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 2 | 2013 | 624 | 0.030 |
Why?
|
| Muscle Contraction | 3 | 1993 | 1207 | 0.030 |
Why?
|
| Hunger | 1 | 2017 | 207 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2023 | 1308 | 0.030 |
Why?
|
| Respiratory Mechanics | 2 | 2017 | 719 | 0.030 |
Why?
|
| Bradycardia | 1 | 2017 | 304 | 0.030 |
Why?
|
| Educational Status | 5 | 1995 | 2510 | 0.030 |
Why?
|
| Dust | 2 | 1990 | 489 | 0.030 |
Why?
|
| Radioisotopes | 1 | 1977 | 498 | 0.030 |
Why?
|
| Lactation | 1 | 2018 | 391 | 0.030 |
Why?
|
| Algorithms | 3 | 2015 | 14064 | 0.030 |
Why?
|
| Chromosomes | 1 | 1978 | 578 | 0.030 |
Why?
|
| Tobramycin | 1 | 2015 | 65 | 0.030 |
Why?
|
| Patient Education as Topic | 4 | 2015 | 2331 | 0.030 |
Why?
|
| Iron | 2 | 2022 | 1811 | 0.030 |
Why?
|
| Physical Stimulation | 1 | 2016 | 513 | 0.030 |
Why?
|
| Curriculum | 4 | 2021 | 3784 | 0.030 |
Why?
|
| Health Status Indicators | 3 | 2012 | 967 | 0.030 |
Why?
|
| Integrin beta3 | 1 | 2015 | 120 | 0.030 |
Why?
|
| Tooth Loss | 2 | 1994 | 198 | 0.030 |
Why?
|
| Respiratory System | 2 | 1996 | 562 | 0.030 |
Why?
|
| Biological Availability | 1 | 2015 | 387 | 0.030 |
Why?
|
| Louisiana | 3 | 2002 | 104 | 0.030 |
Why?
|
| Radioimmunoassay | 2 | 1972 | 860 | 0.030 |
Why?
|
| Glycerol Kinase | 1 | 2014 | 15 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 1 | 2015 | 239 | 0.030 |
Why?
|
| Leptin | 2 | 2013 | 1596 | 0.030 |
Why?
|
| Classification | 1 | 1995 | 128 | 0.030 |
Why?
|
| Carbon Tetrachloride | 1 | 2014 | 72 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2010 | 4044 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 3360 | 0.030 |
Why?
|
| Physical Fitness | 2 | 2015 | 742 | 0.030 |
Why?
|
| Toxins, Biological | 1 | 2014 | 59 | 0.030 |
Why?
|
| Academic Medical Centers | 2 | 2017 | 2782 | 0.030 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2014 | 32 | 0.030 |
Why?
|
| Dietary Proteins | 3 | 2007 | 960 | 0.030 |
Why?
|
| Hematologic Tests | 1 | 2015 | 239 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 2 | 2009 | 696 | 0.030 |
Why?
|
| Histamine | 1 | 1996 | 496 | 0.030 |
Why?
|
| Epidemiologic Factors | 1 | 1994 | 36 | 0.030 |
Why?
|
| Skinfold Thickness | 3 | 2000 | 164 | 0.030 |
Why?
|
| Hospitals | 2 | 2005 | 3886 | 0.030 |
Why?
|
| Food Handling | 1 | 1994 | 158 | 0.030 |
Why?
|
| Receptors, Immunologic | 2 | 1991 | 1415 | 0.030 |
Why?
|
| Bronchial Provocation Tests | 2 | 1991 | 216 | 0.030 |
Why?
|
| Achievement | 1 | 2015 | 287 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2005 | 1481 | 0.030 |
Why?
|
| Self-Examination | 1 | 2013 | 71 | 0.030 |
Why?
|
| Methacholine Chloride | 2 | 1991 | 219 | 0.030 |
Why?
|
| Eating | 2 | 2006 | 1539 | 0.030 |
Why?
|
| Proteome | 1 | 2023 | 1896 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 2020 | 2863 | 0.030 |
Why?
|
| C-Peptide | 1 | 2015 | 443 | 0.030 |
Why?
|
| Survivors | 3 | 2011 | 2373 | 0.030 |
Why?
|
| Texas | 3 | 2002 | 410 | 0.030 |
Why?
|
| Internal-External Control | 1 | 1995 | 348 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2015 | 2476 | 0.030 |
Why?
|
| Diphosphonates | 1 | 2018 | 625 | 0.030 |
Why?
|
| Suburban Population | 1 | 1993 | 54 | 0.030 |
Why?
|
| Oral Hygiene | 1 | 1994 | 132 | 0.030 |
Why?
|
| New Hampshire | 1 | 2013 | 174 | 0.030 |
Why?
|
| Bronchi | 3 | 1988 | 843 | 0.030 |
Why?
|
| Body Fluids | 1 | 1994 | 320 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2023 | 8279 | 0.030 |
Why?
|
| Intercostal Muscles | 4 | 1993 | 26 | 0.030 |
Why?
|
| Guideline Adherence | 2 | 2017 | 2234 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 6360 | 0.030 |
Why?
|
| Thyrotropin | 1 | 2016 | 834 | 0.030 |
Why?
|
| Periodontal Index | 2 | 2008 | 149 | 0.030 |
Why?
|
| Hospitals, Pediatric | 2 | 2015 | 1850 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2017 | 786 | 0.020 |
Why?
|
| Decanoic Acids | 2 | 1991 | 68 | 0.020 |
Why?
|
| Neoplasm Metastasis | 2 | 2013 | 4882 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2023 | 2969 | 0.020 |
Why?
|
| Sodium, Dietary | 3 | 2002 | 426 | 0.020 |
Why?
|
| Emergencies | 1 | 1998 | 1221 | 0.020 |
Why?
|
| Lung Compliance | 1 | 1992 | 207 | 0.020 |
Why?
|
| Catenins | 1 | 2011 | 44 | 0.020 |
Why?
|
| RNA | 1 | 2021 | 2716 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 9373 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 1996 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 2017 | 912 | 0.020 |
Why?
|
| SRS-A | 1 | 1991 | 132 | 0.020 |
Why?
|
| Carbon Dioxide | 3 | 1985 | 1138 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2018 | 2075 | 0.020 |
Why?
|
| Bone Resorption | 1 | 2015 | 717 | 0.020 |
Why?
|
| Activities of Daily Living | 2 | 2007 | 2414 | 0.020 |
Why?
|
| Meat | 1 | 1994 | 588 | 0.020 |
Why?
|
| Calcium, Dietary | 2 | 2006 | 527 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 5379 | 0.020 |
Why?
|
| Polysomnography | 1 | 2018 | 1868 | 0.020 |
Why?
|
| Dermatitis, Occupational | 1 | 1991 | 26 | 0.020 |
Why?
|
| Vitamin B 6 | 1 | 2012 | 237 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2022 | 2031 | 0.020 |
Why?
|
| Physical Examination | 2 | 2013 | 1263 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 12973 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2012 | 279 | 0.020 |
Why?
|
| Printing | 1 | 1991 | 47 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2016 | 1130 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2013 | 9656 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 10256 | 0.020 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 1991 | 191 | 0.020 |
Why?
|
| Veins | 1 | 2015 | 768 | 0.020 |
Why?
|
| Seasons | 2 | 2009 | 1522 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 931 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2014 | 910 | 0.020 |
Why?
|
| Gingival Recession | 1 | 1994 | 210 | 0.020 |
Why?
|
| Water | 1 | 2017 | 1416 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2014 | 543 | 0.020 |
Why?
|
| Petrous Bone | 1 | 2011 | 85 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2006 | 4305 | 0.020 |
Why?
|
| Byssinosis | 1 | 1990 | 36 | 0.020 |
Why?
|
| Gossypium | 1 | 1990 | 36 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2005 | 3444 | 0.020 |
Why?
|
| Amino Acids | 1 | 2017 | 1709 | 0.020 |
Why?
|
| Hyperparathyroidism | 1 | 2012 | 338 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2019 | 3158 | 0.020 |
Why?
|
| Calcifediol | 1 | 2011 | 156 | 0.020 |
Why?
|
| California | 3 | 2002 | 1435 | 0.020 |
Why?
|
| Neuropeptides | 1 | 1996 | 952 | 0.020 |
Why?
|
| Phagosomes | 1 | 1991 | 193 | 0.020 |
Why?
|
| Food Deprivation | 1 | 1990 | 115 | 0.020 |
Why?
|
| Blood Proteins | 2 | 1975 | 1186 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2023 | 3586 | 0.020 |
Why?
|
| Homes for the Aged | 1 | 1992 | 273 | 0.020 |
Why?
|
| Age Determination by Skeleton | 1 | 2010 | 124 | 0.020 |
Why?
|
| Cellulose | 1 | 1990 | 116 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2016 | 960 | 0.020 |
Why?
|
| Breast Neoplasms | 4 | 1998 | 21069 | 0.020 |
Why?
|
| Chimerism | 1 | 2011 | 154 | 0.020 |
Why?
|
| Appetite Depressants | 1 | 2010 | 108 | 0.020 |
Why?
|
| Headache | 2 | 2013 | 1261 | 0.020 |
Why?
|
| Necrosis | 1 | 2014 | 1611 | 0.020 |
Why?
|
| Fruit | 1 | 2015 | 1167 | 0.020 |
Why?
|
| Vegetables | 1 | 2015 | 1200 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1972 | 824 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 1996 | 1740 | 0.020 |
Why?
|
| Laxatives | 1 | 2010 | 94 | 0.020 |
Why?
|
| Galectin 3 | 1 | 2011 | 238 | 0.020 |
Why?
|
| Wrist Joint | 1 | 2011 | 264 | 0.020 |
Why?
|
| Phenotype | 2 | 2023 | 16714 | 0.020 |
Why?
|
| F2-Isoprostanes | 1 | 2009 | 35 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 1167 | 0.020 |
Why?
|
| Shigella dysenteriae | 1 | 1989 | 14 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2010 | 317 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1996 | 2543 | 0.020 |
Why?
|
| Urine | 1 | 1991 | 363 | 0.020 |
Why?
|
| Epinephrine | 1 | 2013 | 782 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2017 | 2925 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2014 | 1964 | 0.020 |
Why?
|
| Cortisone | 1 | 1989 | 90 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2014 | 1563 | 0.020 |
Why?
|
| Pokeweed Mitogens | 1 | 2009 | 37 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2015 | 846 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2014 | 719 | 0.020 |
Why?
|
| Haplotypes | 1 | 2015 | 2726 | 0.020 |
Why?
|
| Semicircular Canals | 1 | 2011 | 203 | 0.020 |
Why?
|
| Chemistry | 2 | 1983 | 325 | 0.020 |
Why?
|
| Diphtheria Toxoid | 1 | 2009 | 25 | 0.020 |
Why?
|
| Respiration, Artificial | 3 | 2017 | 2726 | 0.020 |
Why?
|
| Phytohemagglutinins | 1 | 2009 | 164 | 0.020 |
Why?
|
| Asthma | 2 | 2006 | 6268 | 0.020 |
Why?
|
| Cochlear Nerve | 1 | 2011 | 202 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 2419 | 0.020 |
Why?
|
| Chemical Phenomena | 2 | 1983 | 483 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 3 | 1998 | 3230 | 0.020 |
Why?
|
| Concanavalin A | 1 | 2009 | 189 | 0.020 |
Why?
|
| Urban Health | 2 | 2006 | 531 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1886 | 0.020 |
Why?
|
| Hippocampus | 1 | 2021 | 3772 | 0.020 |
Why?
|
| Maximal Expiratory Flow Rate | 1 | 1988 | 42 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2013 | 698 | 0.020 |
Why?
|
| Respiratory Function Tests | 3 | 1989 | 1692 | 0.020 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 1988 | 76 | 0.020 |
Why?
|
| Internal Medicine | 1 | 1996 | 1064 | 0.020 |
Why?
|
| Likelihood Functions | 2 | 2006 | 993 | 0.020 |
Why?
|
| Dysentery, Bacillary | 1 | 1989 | 73 | 0.020 |
Why?
|
| Survival Rate | 3 | 2010 | 12822 | 0.020 |
Why?
|
| Cytotoxins | 1 | 1989 | 154 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2010 | 527 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 544 | 0.020 |
Why?
|
| Tetanus Toxoid | 1 | 2009 | 186 | 0.020 |
Why?
|
| Binge-Eating Disorder | 1 | 2010 | 156 | 0.020 |
Why?
|
| Recurrence | 2 | 2009 | 8492 | 0.020 |
Why?
|
| Health Services Needs and Demand | 2 | 1994 | 1404 | 0.020 |
Why?
|
| Bulimia Nervosa | 1 | 2010 | 208 | 0.020 |
Why?
|
| Maximal Midexpiratory Flow Rate | 1 | 1988 | 75 | 0.020 |
Why?
|
| Berylliosis | 1 | 1988 | 9 | 0.020 |
Why?
|
| Social Class | 1 | 1997 | 2007 | 0.020 |
Why?
|
| Data Collection | 2 | 1995 | 3318 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2004 | 6274 | 0.020 |
Why?
|
| Alcoholism | 2 | 1990 | 1978 | 0.020 |
Why?
|
| Transsexualism | 1 | 2012 | 210 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 2011 | 879 | 0.020 |
Why?
|
| Immobilization | 1 | 2009 | 226 | 0.020 |
Why?
|
| Dyspnea | 1 | 1996 | 1351 | 0.020 |
Why?
|
| Osteolysis | 1 | 2010 | 271 | 0.020 |
Why?
|
| Acute Disease | 2 | 2014 | 7236 | 0.020 |
Why?
|
| Inhalation | 1 | 1988 | 142 | 0.020 |
Why?
|
| Genomics | 1 | 2024 | 5925 | 0.020 |
Why?
|
| Radiography, Panoramic | 1 | 2008 | 110 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2018 | 3087 | 0.020 |
Why?
|
| Siblings | 1 | 2012 | 828 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 2008 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2013 | 993 | 0.020 |
Why?
|
| Air Pollutants, Occupational | 1 | 1990 | 406 | 0.020 |
Why?
|
| Dietary Fiber | 2 | 2002 | 767 | 0.020 |
Why?
|
| Pulmonary Ventilation | 1 | 1989 | 375 | 0.020 |
Why?
|
| Methacholine Compounds | 1 | 1987 | 35 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2013 | 2915 | 0.020 |
Why?
|
| Satiety Response | 1 | 2007 | 47 | 0.020 |
Why?
|
| Hyaline Membrane Disease | 1 | 1987 | 19 | 0.020 |
Why?
|
| Health Status | 2 | 1997 | 4085 | 0.020 |
Why?
|
| Steroid 21-Hydroxylase | 1 | 2007 | 32 | 0.020 |
Why?
|
| Diuretics | 1 | 2010 | 611 | 0.020 |
Why?
|
| Running | 1 | 2012 | 488 | 0.020 |
Why?
|
| Albuminuria | 1 | 1991 | 659 | 0.020 |
Why?
|
| Vomiting | 1 | 2010 | 646 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2013 | 1140 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 1695 | 0.020 |
Why?
|
| Sulfur Dioxide | 1 | 1987 | 178 | 0.020 |
Why?
|
| Viscosity | 1 | 1987 | 334 | 0.020 |
Why?
|
| Stroboscopy | 1 | 2007 | 62 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 13631 | 0.020 |
Why?
|
| Rats, Inbred Strains | 4 | 1990 | 2077 | 0.020 |
Why?
|
| Cattle | 3 | 1994 | 3801 | 0.020 |
Why?
|
| Tomography | 1 | 2009 | 443 | 0.020 |
Why?
|
| Cadherins | 1 | 2011 | 899 | 0.020 |
Why?
|
| Muscular Atrophy | 1 | 1989 | 335 | 0.020 |
Why?
|
| Talc | 1 | 1987 | 48 | 0.020 |
Why?
|
| Wrist | 1 | 2008 | 230 | 0.020 |
Why?
|
| Length of Stay | 2 | 2013 | 6486 | 0.020 |
Why?
|
| Bronchitis | 1 | 1987 | 193 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 1996 | 5531 | 0.020 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2007 | 186 | 0.020 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 1 | 2005 | 55 | 0.020 |
Why?
|
| Cytoplasm | 2 | 1987 | 1498 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2010 | 966 | 0.020 |
Why?
|
| Serum Sickness | 1 | 2005 | 25 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2010 | 641 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 1987 | 169 | 0.020 |
Why?
|
| Food Analysis | 1 | 2006 | 103 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2010 | 634 | 0.020 |
Why?
|
| Silicon Dioxide | 1 | 1987 | 218 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 7423 | 0.020 |
Why?
|
| Gingival Hemorrhage | 2 | 1996 | 49 | 0.020 |
Why?
|
| Amenorrhea | 1 | 2009 | 470 | 0.020 |
Why?
|
| Attitude of Health Personnel | 2 | 1997 | 3928 | 0.020 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2007 | 292 | 0.020 |
Why?
|
| Hip Joint | 1 | 2012 | 1000 | 0.020 |
Why?
|
| Immersion | 1 | 1985 | 38 | 0.020 |
Why?
|
| Fever | 1 | 2013 | 1607 | 0.020 |
Why?
|
| Mass Screening | 2 | 2000 | 5449 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2023 | 11895 | 0.020 |
Why?
|
| Fiber Optic Technology | 1 | 2007 | 290 | 0.020 |
Why?
|
| Forms and Records Control | 1 | 2005 | 158 | 0.020 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2005 | 70 | 0.020 |
Why?
|
| Carbonated Beverages | 1 | 2006 | 209 | 0.010 |
Why?
|
| Life Tables | 1 | 2005 | 366 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2014 | 4257 | 0.010 |
Why?
|
| Periodontal Attachment Loss | 2 | 1996 | 151 | 0.010 |
Why?
|
| Pulmonary Emphysema | 1 | 1990 | 683 | 0.010 |
Why?
|
| Motivation | 1 | 1995 | 2018 | 0.010 |
Why?
|
| Periodontal Pocket | 2 | 1996 | 174 | 0.010 |
Why?
|
| Nursing Homes | 1 | 1992 | 1084 | 0.010 |
Why?
|
| Milk | 1 | 2007 | 436 | 0.010 |
Why?
|
| Chemistry, Clinical | 1 | 2005 | 64 | 0.010 |
Why?
|
| Aminoglycosides | 1 | 2005 | 161 | 0.010 |
Why?
|
| Morbidity | 2 | 2000 | 1752 | 0.010 |
Why?
|
| ROC Curve | 2 | 2004 | 3612 | 0.010 |
Why?
|
| Cochlea | 1 | 2011 | 848 | 0.010 |
Why?
|
| Models, Animal | 1 | 2011 | 2120 | 0.010 |
Why?
|
| Colorimetry | 1 | 2005 | 147 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 2007 | 913 | 0.010 |
Why?
|
| Tyrosine Transaminase | 1 | 1984 | 11 | 0.010 |
Why?
|
| Rats | 7 | 1990 | 23708 | 0.010 |
Why?
|
| Age of Onset | 1 | 2011 | 3343 | 0.010 |
Why?
|
| Glycogen | 1 | 2005 | 252 | 0.010 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2005 | 244 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2022 | 11639 | 0.010 |
Why?
|
| Phorbols | 1 | 1983 | 44 | 0.010 |
Why?
|
| Counterpulsation | 1 | 2003 | 16 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2014 | 3225 | 0.010 |
Why?
|
| Lipoproteins | 2 | 2002 | 870 | 0.010 |
Why?
|
| Weight-Bearing | 1 | 2007 | 529 | 0.010 |
Why?
|
| Self Report | 1 | 2015 | 3768 | 0.010 |
Why?
|
| Biochemistry | 1 | 2005 | 115 | 0.010 |
Why?
|
| Estradiol | 2 | 2002 | 1947 | 0.010 |
Why?
|
| Phorbol Esters | 1 | 1983 | 108 | 0.010 |
Why?
|
| Transplantation Conditioning | 1 | 2011 | 1635 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2014 | 2963 | 0.010 |
Why?
|
| Patient Satisfaction | 2 | 2007 | 3477 | 0.010 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2005 | 256 | 0.010 |
Why?
|
| Gastrointestinal Tract | 1 | 2010 | 833 | 0.010 |
Why?
|
| Dogs | 4 | 1992 | 3824 | 0.010 |
Why?
|
| Foreign Bodies | 1 | 1988 | 402 | 0.010 |
Why?
|
| Receptors, Drug | 1 | 1983 | 156 | 0.010 |
Why?
|
| Guinea Pigs | 2 | 1996 | 1300 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 1990 | 1467 | 0.010 |
Why?
|
| Pentobarbital | 1 | 2004 | 153 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 1989 | 924 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2008 | 1818 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2010 | 1260 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 4859 | 0.010 |
Why?
|
| Reflex | 1 | 1985 | 376 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 3606 | 0.010 |
Why?
|
| Knee Joint | 1 | 2011 | 1656 | 0.010 |
Why?
|
| Tidal Volume | 4 | 1988 | 519 | 0.010 |
Why?
|
| Remission Induction | 1 | 2009 | 2413 | 0.010 |
Why?
|
| Fasting | 1 | 2009 | 1606 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3801 | 0.010 |
Why?
|
| Ligands | 2 | 1983 | 3272 | 0.010 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1985 | 239 | 0.010 |
Why?
|
| Occupational Diseases | 1 | 1991 | 1456 | 0.010 |
Why?
|
| Diazepam | 1 | 1983 | 215 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 22327 | 0.010 |
Why?
|
| Thyroxine-Binding Proteins | 2 | 1972 | 24 | 0.010 |
Why?
|
| Muscles | 1 | 1987 | 1577 | 0.010 |
Why?
|
| Mouth, Edentulous | 2 | 1993 | 81 | 0.010 |
Why?
|
| Midazolam | 1 | 2004 | 267 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 4423 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 1994 | 2084 | 0.010 |
Why?
|
| Hypertension | 3 | 2000 | 8616 | 0.010 |
Why?
|
| Air Pollutants | 2 | 1991 | 2922 | 0.010 |
Why?
|
| Primary Prevention | 2 | 2002 | 1187 | 0.010 |
Why?
|
| Video Recording | 1 | 2007 | 977 | 0.010 |
Why?
|
| Prostatic Neoplasms | 2 | 2001 | 11090 | 0.010 |
Why?
|
| Biopsy | 1 | 2013 | 6766 | 0.010 |
Why?
|
| Naloxone | 1 | 1984 | 373 | 0.010 |
Why?
|
| Iron, Dietary | 1 | 2002 | 148 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2010 | 1204 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 2005 | 578 | 0.010 |
Why?
|
| Dominance-Subordination | 1 | 2000 | 26 | 0.010 |
Why?
|
| Medication Adherence | 1 | 2012 | 2190 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 6491 | 0.010 |
Why?
|
| Parent-Child Relations | 1 | 2006 | 772 | 0.010 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2002 | 357 | 0.010 |
Why?
|
| Pain | 1 | 2016 | 5077 | 0.010 |
Why?
|
| Diabetes Complications | 2 | 2000 | 1318 | 0.010 |
Why?
|
| Alcohol Drinking | 3 | 2000 | 4041 | 0.010 |
Why?
|
| Disease Progression | 2 | 2010 | 13614 | 0.010 |
Why?
|
| Temperance | 1 | 2000 | 88 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6058 | 0.010 |
Why?
|
| Fentanyl | 1 | 2004 | 451 | 0.010 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2005 | 365 | 0.010 |
Why?
|
| Masturbation | 1 | 2000 | 8 | 0.010 |
Why?
|
| Pituitary Hormones | 1 | 2001 | 183 | 0.010 |
Why?
|
| Population | 1 | 2000 | 140 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1982 | 573 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 2007 | 1432 | 0.010 |
Why?
|
| Hematologic Neoplasms | 1 | 2012 | 1926 | 0.010 |
Why?
|
| Regional Medical Programs | 1 | 2000 | 64 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2010 | 4186 | 0.010 |
Why?
|
| Seizures | 1 | 2013 | 2997 | 0.010 |
Why?
|
| Myocardial Revascularization | 1 | 2003 | 795 | 0.010 |
Why?
|
| Hypotension | 1 | 2005 | 885 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 2000 | 222 | 0.010 |
Why?
|
| Ambulances | 1 | 2000 | 94 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2005 | 1137 | 0.010 |
Why?
|
| Cell Movement | 1 | 2011 | 5190 | 0.010 |
Why?
|
| Posture | 1 | 1984 | 955 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1983 | 1055 | 0.010 |
Why?
|
| Receptors, GABA-A | 1 | 1983 | 623 | 0.010 |
Why?
|
| Binding Sites | 3 | 1989 | 5999 | 0.010 |
Why?
|
| Chylomicrons | 1 | 1979 | 26 | 0.010 |
Why?
|
| Inflammation | 1 | 2019 | 10843 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1983 | 1202 | 0.010 |
Why?
|
| Causality | 2 | 1998 | 1247 | 0.010 |
Why?
|
| Pyridoxine | 1 | 1999 | 108 | 0.010 |
Why?
|
| Serum Albumin | 2 | 1972 | 673 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2014 | 14450 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 1982 | 677 | 0.010 |
Why?
|
| Breathing Exercises | 1 | 1979 | 59 | 0.010 |
Why?
|
| Methods | 2 | 1978 | 1061 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2006 | 1793 | 0.010 |
Why?
|
| Elasticity | 2 | 1992 | 652 | 0.010 |
Why?
|
| Air Pollution | 1 | 1992 | 2380 | 0.010 |
Why?
|
| Time and Motion Studies | 1 | 1998 | 143 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2002 | 646 | 0.010 |
Why?
|
| Anger | 1 | 2000 | 402 | 0.010 |
Why?
|
| Self-Assessment | 1 | 2000 | 401 | 0.010 |
Why?
|
| Serum Albumin, Radio-Iodinated | 1 | 1977 | 37 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 5500 | 0.010 |
Why?
|
| Body Image | 1 | 2002 | 645 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2004 | 1394 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2013 | 8060 | 0.010 |
Why?
|
| Mass Media | 1 | 2000 | 302 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2007 | 2155 | 0.010 |
Why?
|
| Particle Size | 2 | 1991 | 1630 | 0.010 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1983 | 887 | 0.010 |
Why?
|
| Ergometry | 1 | 1996 | 17 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2004 | 1457 | 0.010 |
Why?
|
| Reinforcement, Social | 1 | 1996 | 11 | 0.010 |
Why?
|
| Biometry | 1 | 2000 | 571 | 0.010 |
Why?
|
| Apolipoproteins | 1 | 1979 | 327 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2005 | 1241 | 0.010 |
Why?
|
| Apolipoproteins B | 1 | 1998 | 385 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1984 | 1962 | 0.010 |
Why?
|
| Dentition | 1 | 1996 | 20 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2002 | 1206 | 0.010 |
Why?
|
| Psychology, Social | 1 | 1996 | 52 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 16039 | 0.010 |
Why?
|
| Tooth Crown | 1 | 1996 | 59 | 0.010 |
Why?
|
| Vitamin B 12 | 1 | 1999 | 531 | 0.010 |
Why?
|
| Risk | 2 | 1999 | 9599 | 0.010 |
Why?
|
| Aorta | 1 | 1983 | 2040 | 0.010 |
Why?
|
| Hypnotics and Sedatives | 1 | 2004 | 1192 | 0.010 |
Why?
|
| Quartz | 2 | 1987 | 23 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10426 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2006 | 2004 | 0.010 |
Why?
|
| Patient-Centered Care | 1 | 2006 | 1447 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 8603 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 11196 | 0.010 |
Why?
|
| Tooth Root | 1 | 1996 | 161 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2005 | 1516 | 0.010 |
Why?
|
| Functional Residual Capacity | 1 | 1994 | 70 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 17060 | 0.010 |
Why?
|
| Dental Calculus | 1 | 1994 | 12 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2010 | 4855 | 0.010 |
Why?
|
| Partial Pressure | 2 | 1985 | 247 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2005 | 1604 | 0.010 |
Why?
|
| Plants, Toxic | 1 | 1993 | 70 | 0.010 |
Why?
|
| Niacin | 1 | 1994 | 116 | 0.010 |
Why?
|
| Trachea | 2 | 1990 | 1091 | 0.010 |
Why?
|
| Nutrition Surveys | 1 | 2000 | 1735 | 0.010 |
Why?
|
| Glucose | 1 | 2005 | 4335 | 0.010 |
Why?
|
| Jaw, Edentulous, Partially | 1 | 1993 | 82 | 0.010 |
Why?
|
| Specialization | 1 | 1997 | 779 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1994 | 938 | 0.010 |
Why?
|
| Rural Health | 1 | 1994 | 301 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1972 | 152 | 0.010 |
Why?
|
| Malpractice | 1 | 1997 | 561 | 0.010 |
Why?
|
| Serum Globulins | 1 | 1972 | 23 | 0.010 |
Why?
|
| Placental Lactogen | 1 | 1972 | 17 | 0.010 |
Why?
|
| Jaw, Edentulous | 1 | 1993 | 94 | 0.010 |
Why?
|
| Transcortin | 1 | 1972 | 12 | 0.010 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 1992 | 91 | 0.010 |
Why?
|
| Gingivitis | 1 | 1993 | 125 | 0.010 |
Why?
|
| Mucoproteins | 1 | 1972 | 49 | 0.010 |
Why?
|
| Critical Care | 1 | 1985 | 2713 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2001 | 1881 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1972 | 340 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 1975 | 643 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1978 | 2196 | 0.010 |
Why?
|
| Muscle Development | 1 | 1993 | 258 | 0.010 |
Why?
|
| Immune Sera | 1 | 1972 | 601 | 0.010 |
Why?
|
| Biotransformation | 1 | 1991 | 165 | 0.010 |
Why?
|
| Electromyography | 2 | 1988 | 1398 | 0.010 |
Why?
|
| Oils, Volatile | 1 | 1991 | 14 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2001 | 2463 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 1991 | 135 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 1972 | 193 | 0.010 |
Why?
|
| Alkanes | 1 | 1991 | 39 | 0.010 |
Why?
|
| gamma-Glutamyltransferase | 1 | 1991 | 141 | 0.010 |
Why?
|
| Petroleum | 1 | 1991 | 82 | 0.010 |
Why?
|
| Dermatitis, Contact | 1 | 1991 | 134 | 0.010 |
Why?
|
| Receptors, Leukotriene | 1 | 1991 | 97 | 0.010 |
Why?
|
| Peptides | 1 | 2002 | 4331 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1994 | 931 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1983 | 4503 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1991 | 655 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1972 | 607 | 0.010 |
Why?
|
| Animal Husbandry | 1 | 1990 | 64 | 0.010 |
Why?
|
| Program Development | 1 | 1996 | 1297 | 0.010 |
Why?
|
| Epithelium | 1 | 1994 | 1603 | 0.010 |
Why?
|
| Isoxazoles | 1 | 1991 | 233 | 0.010 |
Why?
|
| Hematuria | 1 | 1991 | 232 | 0.010 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1989 | 47 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1972 | 567 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1972 | 731 | 0.010 |
Why?
|
| Shiga Toxins | 1 | 1989 | 39 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 1972 | 828 | 0.010 |
Why?
|
| Tunicamycin | 1 | 1989 | 107 | 0.000 |
Why?
|
| Medicine | 1 | 1997 | 944 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2003 | 12529 | 0.000 |
Why?
|
| Physical Exertion | 1 | 1991 | 666 | 0.000 |
Why?
|
| Acetylglucosaminidase | 1 | 1987 | 66 | 0.000 |
Why?
|
| Periodontitis | 1 | 1993 | 576 | 0.000 |
Why?
|
| Patient Participation | 1 | 1997 | 1447 | 0.000 |
Why?
|
| Prostatic Hyperplasia | 1 | 1991 | 514 | 0.000 |
Why?
|
| Analgesics, Opioid | 1 | 2004 | 3834 | 0.000 |
Why?
|
| Peroxidases | 1 | 1987 | 134 | 0.000 |
Why?
|
| Rabbits | 1 | 1993 | 4729 | 0.000 |
Why?
|
| Lectins | 1 | 1989 | 487 | 0.000 |
Why?
|
| Tissue Distribution | 1 | 1991 | 2270 | 0.000 |
Why?
|
| Temperature | 1 | 1993 | 2226 | 0.000 |
Why?
|
| Forced Expiratory Volume | 1 | 1991 | 1828 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1987 | 695 | 0.000 |
Why?
|
| Thermodynamics | 1 | 1987 | 577 | 0.000 |
Why?
|
| Phagocytosis | 1 | 1991 | 1517 | 0.000 |
Why?
|
| Clone Cells | 1 | 1989 | 1670 | 0.000 |
Why?
|
| Income | 1 | 1994 | 1874 | 0.000 |
Why?
|
| Vital Capacity | 1 | 1988 | 995 | 0.000 |
Why?
|
| Epitopes | 1 | 1972 | 2523 | 0.000 |
Why?
|
| Stress, Psychological | 1 | 2000 | 4527 | 0.000 |
Why?
|
| Mutation | 1 | 2010 | 30192 | 0.000 |
Why?
|
| Patient Admission | 1 | 1992 | 1365 | 0.000 |
Why?
|
| Mucus | 1 | 1987 | 346 | 0.000 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1985 | 116 | 0.000 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1987 | 389 | 0.000 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 1985 | 143 | 0.000 |
Why?
|
| Heart Rate | 1 | 1996 | 4203 | 0.000 |
Why?
|
| Organ Size | 1 | 1989 | 2261 | 0.000 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 1983 | 40 | 0.000 |
Why?
|
| Cell Line | 2 | 1991 | 15540 | 0.000 |
Why?
|
| Octoxynol | 1 | 1983 | 76 | 0.000 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1983 | 139 | 0.000 |
Why?
|
| Biological Assay | 1 | 1987 | 626 | 0.000 |
Why?
|
| Blood Gas Analysis | 1 | 1985 | 382 | 0.000 |
Why?
|
| Phospholipids | 1 | 1987 | 776 | 0.000 |
Why?
|
| Enzyme Induction | 1 | 1984 | 456 | 0.000 |
Why?
|
| HeLa Cells | 1 | 1989 | 3070 | 0.000 |
Why?
|
| Electric Stimulation | 1 | 1987 | 1738 | 0.000 |
Why?
|
| Therapeutic Irrigation | 1 | 1983 | 297 | 0.000 |
Why?
|
| Mental Health | 1 | 1996 | 3272 | 0.000 |
Why?
|
| Thorax | 1 | 1985 | 554 | 0.000 |
Why?
|
| Chick Embryo | 1 | 1984 | 964 | 0.000 |
Why?
|
| Cell Survival | 1 | 1991 | 5745 | 0.000 |
Why?
|
| Neoplasms | 1 | 2010 | 22340 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1991 | 2674 | 0.000 |
Why?
|
| Fatigue | 1 | 1987 | 1553 | 0.000 |
Why?
|
| Species Specificity | 1 | 1984 | 2406 | 0.000 |
Why?
|
| Physicians | 1 | 1997 | 4591 | 0.000 |
Why?
|
| Cognition | 1 | 1996 | 7043 | 0.000 |
Why?
|
| Polyethylene Glycols | 1 | 1983 | 1189 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1987 | 4161 | 0.000 |
Why?
|
| Immunodiffusion | 1 | 1975 | 140 | 0.000 |
Why?
|
| Pituitary Neoplasms | 1 | 1983 | 1322 | 0.000 |
Why?
|
| Software | 1 | 1989 | 4462 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1983 | 2864 | 0.000 |
Why?
|
| Monte Carlo Method | 1 | 1978 | 1238 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1987 | 18962 | 0.000 |
Why?
|
| Skin | 1 | 1985 | 4481 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1987 | 8037 | 0.000 |
Why?
|
| Neutrophils | 1 | 1983 | 3769 | 0.000 |
Why?
|
| Epithelial Cells | 1 | 1982 | 3684 | 0.000 |
Why?
|
| Carrier Proteins | 1 | 1983 | 4909 | 0.000 |
Why?
|